| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |